Marram Ventures Launches as Standalone Healthcare Venture Firm
Scott Lancaster Mariya Filipova $25 million deployed in 24 months across portfolio companies backed by Mayo Clinic, a16z and Khosla Ventures SHERIDAN, WY, UNITED STATES, June 30, 2026 / EINPresswire.com / -- Marram Ventures today announced its establishment as a standalone venture capital firm following the transition of Arcis Fund I and related investment management activities from The 4100 Group. The independent firm manages committed capital through Arcis Fund I and advises on additional venture and healthcare investments at The 4100 Group, representing approximately $80 million in total assets under management or advisement. Marram is built around a conviction still rare in venture: that the body is one connected system, and the companies worth backing are those treating it that way. The firm invests in whole-person healthcare — across physical, mental and oral health — committing $1–3 million checks in Seed through Series B companies. Marram is led by Partners ...
